Clin2
NCT05095701Possibly a fitEnrolling by invitation

Study tracks lasting protection from a live chickenpox vaccine

Varicella

Part of Infections clinical trials.

This trial follows people who previously took a chickenpox (varicella) vaccine to see how long their immune protection lasts. It may help explain who stays protected over time and for how long.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
703 people
Ages
1 year to 17 years
Study type
Interventional

Who can take part

  • You took part in the earlier phase 3 chickenpox vaccine study’s “immunity” group
  • You (or your guardian) can understand the study and sign consent
  • You have a legal identity recognized for the study
  • No previous history of chickenpox or shingles
  • No chickenpox vaccination since the earlier phase 3 study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06484686Enrolling by invitation· Phase 4
Long-term immunity study of chickenpox vaccine booster

This study follows up people who were in a previous phase 3 chickenpox vaccine trial. It checks how long protection from a booster dose lasts, by taking a blood sample.

Zhengzhou, Henan
NCT06482216Not yet recruiting
Chickenpox protection study in children with close contact

This study looks at how well the chickenpox vaccine protects children who have been around someone with chickenpox. It may help doctors understand who is most likely to get sick.

NCT05422508Recruiting· Phase 2
Second chickenpox shot for healthy kids after one prior vaccine

This study gives a second chickenpox vaccine dose to healthy children who were vaccinated once before. It mainly checks safety and measures the body’s immune response to see how well the second dose works.

Ansan
NCT07633197Enrolling by invitation· Phase 1
Testing a new shingles vaccine for adults over 40

This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.

Zhengzhou, Henan
NCT07473427Not yet recruiting· Phase 3
Chickenpox vaccine study for healthy children aged 1 to 12

This study tests a chickenpox (varicella) vaccine in healthy children to see how well it works and if it is safe. It may help protect your child from chickenpox.

Hanoi
NCT07054099Recruiting· Phase 3
Testing a chickenpox vaccine for children ages 1 to 12

This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.

Khon Kaen, Changwat Khon Kaen

Hear when a new Varicella trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.